These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2699463)

  • 1. Therapy with growth hormone--old and new indications.
    Bierich JR
    Horm Res; 1989; 32(5-6):153-65. PubMed ID: 2699463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone therapy in short children without classical growth hormone deficiency.
    Bierich JR
    J Endocrinol Invest; 1989; 12(8 Suppl 3):25-33. PubMed ID: 2681346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children.
    Ishikawa M; Yokoya S; Tachibana K; Hasegawa Y; Yasuda T; Tokuhiro E; Hashimoto Y; Tanaka T
    J Clin Endocrinol Metab; 1999 Jan; 84(1):98-104. PubMed ID: 9920068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New findings and the potential use of the growth hormone].
    Sotos JF
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():166-9. PubMed ID: 1636958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO; Albertsson-Wikland K; Alm J; Aronson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson SA; Karlberg J; Kriström B; Marcus C; Moell C; Ritzen M; Tuvemo T; Wattsgård C; Westgren U; Westphal O; Aman J
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
    Saggese G; Federico G; Cinquanta L
    Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and endocrine disorders secondary to cranial irradiation.
    Rappaport R; Brauner R
    Pediatr Res; 1989 Jun; 25(6):561-7. PubMed ID: 2662128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of treatment in Turner's syndrome.
    Gracia Bouthelier R; Oliver Iguacel A; Gonzalez Casado I; Alcalde de Alvaré A
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():427-34. PubMed ID: 15134303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low urinary growth hormone values in patients with Turner's syndrome.
    Kohno H; Honda S
    J Clin Endocrinol Metab; 1992 Mar; 74(3):619-22. PubMed ID: 1740496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutional delay in growth and puberty: a comparison of final height achieved between treated and untreated children.
    Ferrández Longás A; Mayayo E; Valle A; Soria J; Labarta JI
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():345-57. PubMed ID: 8887180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone in the treatment of children with short stature.
    Pediatrics; 1983 Dec; 72(6):891-4. PubMed ID: 6646934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment by hGH of constitutional delay of growth and adolescence.
    Bierich JR
    Acta Paediatr Scand Suppl; 1986; 325():71-5. PubMed ID: 3296641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and diagnostic approach to children of low stature. Evaluation of a 24-month hGH treatment of patients with growth impairment of diverse etiopathogenesis].
    Azzaroli L; Zucchini A; Manfredi R; Demaria F; Manfredi G
    Pediatr Med Chir; 1992; 14(3):279-83. PubMed ID: 1528795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA; Marchisotti FG; Montenegro LR; Carvalho LR; Mendonca BB; Arnhold IJ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1076-80. PubMed ID: 16291702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacologic treatment of constitutional short stature].
    Zaccaria M
    Minerva Endocrinol; 1990; 15(1):73-8. PubMed ID: 2274017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness of growth hormone-deficient children to human growth hormone. Effect of replacement therapy for one year.
    Rudman D; Patterson JH; Gibbas DL
    J Clin Invest; 1973 May; 52(5):1108-12. PubMed ID: 4700485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.